Bell Biosystems
Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.
Launch date
Employees
Market cap
-
Enterprise valuation
€14—21m (Dealroom.co estimates Apr 2015.)
San Francisco California (HQ)
Authorizing premium user...